Scar Tissue & Fibrosis Support Injection – Longidaza 3000 IU Bovhyaluronidase Azoximer – 5 Vials
$169.99
Out of stock
Description
Longidaza 3000 IU is an enzyme medicine supplied as a lyophilized powder for preparing an injection solution. Each vial contains bovhyaluronidase azoximer 3000 IU. Current Russian prescribing information lists it for use in adults as part of complex therapy for conditions associated with connective-tissue hyperplasia, adhesions, fibrosis, and scar formation in several medical specialties.
The product is supplied in 5 vials and is manufactured by NPO Petrovax Pharm.
Benefits
- Enzyme-based therapy
- Used in approved markets for conditions associated with fibrosis and excessive connective-tissue formation
- May be included in physician-directed treatment of adhesions and scar-related conditions
- Injectable formulation for controlled medical administration
- Each vial provides 3000 IU of bovhyaluronidase azoximer
Active Ingredient
Bovhyaluronidase Azoximer – 3000 IU per vial
Other Ingredient: Mannitol, up to 20 mg per vial.
Dosage Form: Lyophilizate for Preparation of Solution for Injection
Strength: 3000 IU per vial
Package Size: 5 Vials
Brand: Longidaza
Manufacturer / Registration Holder: NPO Petrovax Pharm
Directions for Use
Longidaza injections should be used only as prescribed and administered by a qualified healthcare professional.
- The current prescribing information lists intramuscular and subcutaneous administration.
- A listed single dose is 3000 IU.
- The exact injection site, interval between injections, total number of injections, and treatment course depend on the specific diagnosis and must be determined by the treating physician.
- The lyophilized powder must be properly reconstituted before administration.
- Do not self-inject unless specifically trained and instructed by a healthcare professional.
Product Type
Prescription Enzyme Medication / Injectable Medication
Vendor / Brand
Longidaza / Petrovax Pharm